Therapeutic Agent for Neuroblastoma Targeting ARID3b
OwnerTakumi Era, Shin-Ichi Nishikawainventors
Life of this patent
Estimating the term…
Abstract
It is intended to provide a therapeutic agent for neuroblastoma. More particularly, it is intended to provide the therapeutic agent for neuroblastoma containing an ARID3b inhibitor.
Claims15
A composition for treating neuroblastoma, which contains an ARID3b inhibitor.
A method of screening for an ARID3b inhibitor, the method comprising measuring an activity of inhibiting ARID3b.
A method of suppressing neuroblastoma, the method comprising inhibiting ARID3b.
A method of diagnosing neuroblastoma, the method comprising measuring an expression level of ARID3b in a cell.
A cell in which expression of ARID3b is modified.
An animal in which expression of ARID3b is modified.
A kit for determining neuroblastoma, which contains at least an antibody against ARID3b, or an oligonucleotide that is capable of annealing to an ARID3b-encoding gene or a sequence complementary thereto.
Dependencies are inferred from the claim text.